{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T06:31:21Z","timestamp":1781332281711,"version":"3.54.1"},"reference-count":23,"publisher":"Stanford University Press","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"vor","delay-in-days":730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Mass Spectrometry"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.clinms.2017.07.001","type":"journal-article","created":{"date-parts":[[2017,7,10]],"date-time":"2017-07-10T02:33:42Z","timestamp":1499654022000},"page":"41-48","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["LC\u2013MS\/MS method for quantitation of mycophenolic acid, mycophenolic acid acyl-glucuronide, and 7-O-mycophenolic acid glucuronide in serum"],"prefix":"10.21627","volume":"3","author":[{"given":"Stephen D.","family":"Merrigan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Kish-Trier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse C.","family":"Seegmiller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamisha L.","family":"Johnson-Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4811","reference":[{"issue":"12","key":"10.1016\/j.clinms.2017.07.001_b0005","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nrneph.2014.172","article-title":"Pharmacogenetics and immunosuppressive drugs in solid organ transplantation","volume":"10","author":"van Gelder","year":"2014","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.clinms.2017.07.001_b0010","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jchromb.2011.07.021","article-title":"A high-throughput U-HPLC-MS\/MS assay for the quantification of mycophenolic acid and its major metabolites mycophenolic acid glucuronide and mycophenolic acid acyl-glucuronide in human plasma and urine","volume":"883\u2013884","author":"Klepacki","year":"2012","journal-title":"J. Chromatogr. B"},{"issue":"12","key":"10.1016\/j.clinms.2017.07.001_b0015","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1124\/dmd.110.034249","article-title":"Involvement of carboxylesterase 1 and 2 in the hydrolysis of mycophenolate mofetil","volume":"38","author":"Fujiyama","year":"2010","journal-title":"Drug Metab. Dispos."},{"issue":"36","key":"10.1016\/j.clinms.2017.07.001_b0020","doi-asserted-by":"crossref","first-page":"27286","DOI":"10.1016\/S0021-9258(19)74247-1","article-title":"Characterization of human type I and type II IMP dehydrogenases","volume":"268","author":"Carr","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clinms.2017.07.001_b0025","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1749-6632.1993.tb17144.x","article-title":"Human type I and II IMP dehydrogenases as drug targets","volume":"696","author":"Natsumeda","year":"1993","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"12","key":"10.1016\/j.clinms.2017.07.001_b0030","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1093\/clinchem\/43.12.2312","article-title":"IMP-dehydrogenase inhibition in human lymphocytes and lymphoblasts by mycophenolic acid and mycophenolic acid glucuronide","volume":"43","author":"Griesmacher","year":"1997","journal-title":"Clin. Chem."},{"issue":"1","key":"10.1016\/j.clinms.2017.07.001_b0035","doi-asserted-by":"crossref","first-page":"184","DOI":"10.2215\/CJN.02860806","article-title":"Therapeutic monitoring of mycophenolate mofetil","volume":"2","author":"Jeong","year":"2007","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"3","key":"10.1016\/j.clinms.2017.07.001_b0040","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/clinchem\/46.3.365","article-title":"Determination of the acyl glucuronide metabolite of mycophenolic acid in human plasma by HPLC and Emit","volume":"46","author":"Shipkova","year":"2000","journal-title":"Clin. Chem."},{"issue":"3","key":"10.1016\/j.clinms.2017.07.001_b0045","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/00007691-200206000-00011","article-title":"Pharmacokinetics and protein adduct formation of the pharmacologically active acyl glucuronide metabolite of mycophenolic acid in pediatric renal transplant recipients","volume":"24","author":"Shipkova","year":"2002","journal-title":"Ther. Drug Monit."},{"issue":"1","key":"10.1016\/j.clinms.2017.07.001_b0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00007691-200302000-00001","article-title":"Acyl glucuronide drug metabolites: toxicological and analytical implications","volume":"25","author":"Shipkova","year":"2003","journal-title":"Ther. Drug Monit."},{"issue":"6","key":"10.1016\/j.clinms.2017.07.001_b0055","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2165\/00003088-199834060-00002","article-title":"Clinical pharmacokinetics of mycophenolate mofetil","volume":"34","author":"Bullingham","year":"1998","journal-title":"Clin. Pharmacokinet."},{"issue":"10","key":"10.1016\/j.clinms.2017.07.001_b0060","doi-asserted-by":"crossref","first-page":"751","DOI":"10.2165\/00003088-200241100-00005","article-title":"Enterohepatic circulation: physiological, pharmacokinetic and clinical implications","volume":"41","author":"Roberts","year":"2002","journal-title":"Clin. Pharmacokinet."},{"issue":"4","key":"10.1016\/j.clinms.2017.07.001_b0065","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/clpt.1988.42","article-title":"Therapeutic drug monitoring","volume":"43","author":"Spector","year":"1988","journal-title":"Clin. Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.clinms.2017.07.001_b0070","first-page":"5","article-title":"Pharmacokinetic principles of immunosuppressive drugs","volume":"13","author":"Budde","year":"2008","journal-title":"Ann. Transplant."},{"key":"10.1016\/j.clinms.2017.07.001_b0075","unstructured":"C.A. Burtis E.R. Ashwood D.E. Bruns, Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. Fifth, St 2012 ELSEVIER SAUNDERS Louis, Missouri, USA."},{"issue":"6","key":"10.1016\/j.clinms.2017.07.001_b0080","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1097\/00007691-200412000-00005","article-title":"Comparison of liquid chromatography-tandem mass spectrometry with a commercial enzyme-multiplied immunoassay for the determination of plasma MPA in renal transplant recipients and consequences for therapeutic drug monitoring","volume":"26","author":"Premaud","year":"2004","journal-title":"Ther. Drug Monit."},{"issue":"2","key":"10.1016\/j.clinms.2017.07.001_b0085","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/01.ftd.0000197092.84935.ef","article-title":"Determination of mycophenolic acid plasma levels in renal transplant recipients co-administered sirolimus: comparison of an enzyme multiplied immunoassay technique (EMIT) and liquid chromatography-tandem mass spectrometry","volume":"28","author":"Premaud","year":"2006","journal-title":"Ther. Drug Monit."},{"issue":"10","key":"10.1016\/j.clinms.2017.07.001_b0090","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1373\/clinchem.2006.074336","article-title":"Quantification by liquid chromatography tandem mass spectrometry of mycophenolic acid and its phenol and acyl glucuronide metabolites","volume":"52","author":"Brandhorst","year":"2006","journal-title":"Clin. Chem."},{"issue":"1","key":"10.1016\/j.clinms.2017.07.001_b0095","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/clinchem\/45.1.127","article-title":"Stability of mycophenolic acid and mycophenolic acid glucuronide in human plasma","volume":"45","author":"Shipkova","year":"1999","journal-title":"Clin. Chem."},{"issue":"6","key":"10.1016\/j.clinms.2017.07.001_b0100","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1081\/CLT-200035101","article-title":"Lack of toxic effects following acute overdose of cellcept (mycophenolate mofetil)","volume":"42","author":"Bebarta","year":"2004","journal-title":"J. Toxicol. Clin. Toxicol."},{"issue":"8","key":"10.1016\/j.clinms.2017.07.001_b0105","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1097\/00007890-199804270-00019","article-title":"Decreased protein binding of mycophenolic acid associated with leukopenia in a pancreas transplant recipient with renal failure","volume":"65","author":"Kaplan","year":"1998","journal-title":"Transplantation"},{"issue":"4","key":"10.1016\/j.clinms.2017.07.001_b0110","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/00007691-200408000-00017","article-title":"Severe toxicity associated with a markedly elevated mycophenolic acid free fraction in a renal transplant recipient","volume":"26","author":"Mudge","year":"2004","journal-title":"Ther. Drug Monit."},{"issue":"10","key":"10.1016\/j.clinms.2017.07.001_b0115","doi-asserted-by":"crossref","first-page":"4049","DOI":"10.1016\/j.transproceed.2010.09.029","article-title":"Neither mycophenolate acyl-glucuronide levels nor their areas under the curve are responsible for the gastrointestinal side effects in kidney transplant recipients receiving EC-MPA: a prospective trial","volume":"42","author":"Raggi","year":"2010","journal-title":"Transplant. Proc."}],"container-title":["Clinical Mass Spectrometry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2376999817300053?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2376999817300053?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T03:47:31Z","timestamp":1770263251000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2376999817300053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":23,"alternative-id":["S2376999817300053"],"URL":"https:\/\/doi.org\/10.1016\/j.clinms.2017.07.001","relation":{},"ISSN":["2376-9998"],"issn-type":[{"value":"2376-9998","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"LC\u2013MS\/MS method for quantitation of mycophenolic acid, mycophenolic acid acyl-glucuronide, and 7-O-mycophenolic acid glucuronide in serum","name":"articletitle","label":"Article Title"},{"value":"Clinical Mass Spectrometry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinms.2017.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Association for Mass Spectrometry: Applications to the Clinical Lab (MSACL). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}